T

Tenax Therapeutics
D

TENX

4.59000
USD
0.09
(2.00%)
Pre Open
Volume
40
EPS
0
Div Yield
0
P/E
-0
Market Cap
15,646,879
OverviewSignalsIdeasNews
Related Instruments
    C
    CTR
    -0.170
    (-0.42%)
    40.090 USD
    MCO
    3.99
    (0.87%)
    460.83 USD
    P
    PAY
    -0.640
    (-3.03%)
    20.510 USD
    P
    PPT
    0.04000
    (1.10%)
    3.67000 USD
News

Title: Tenax Therapeutics

Sector: Healthcare
Industry: Biotechnology
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North Americanrights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved EjectionFraction.